273 related articles for article (PubMed ID: 26542979)
1. miR-1343 attenuates pathways of fibrosis by targeting the TGF-β receptors.
Stolzenburg LR; Wachtel S; Dang H; Harris A
Biochem J; 2016 Feb; 473(3):245-56. PubMed ID: 26542979
[TBL] [Abstract][Full Text] [Related]
2. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL
Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417
[TBL] [Abstract][Full Text] [Related]
3. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
Xiang Y; Zhang Y; Tang Y; Li Q
Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
[TBL] [Abstract][Full Text] [Related]
4. The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis.
Liang C; Li X; Zhang L; Cui D; Quan X; Yang W
Exp Mol Pathol; 2015 Oct; 99(2):279-85. PubMed ID: 26216407
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
6. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.
Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P
Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962
[TBL] [Abstract][Full Text] [Related]
8. The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis.
Yan C; Wang L; Li B; Zhang BB; Zhang B; Wang YH; Li XY; Chen JX; Tang RX; Zheng KY
Parasit Vectors; 2015 Feb; 8():70. PubMed ID: 25649869
[TBL] [Abstract][Full Text] [Related]
9. The matricellular protein CCN1 enhances TGF-β1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury.
Kurundkar AR; Kurundkar D; Rangarajan S; Locy ML; Zhou Y; Liu RM; Zmijewski J; Thannickal VJ
FASEB J; 2016 Jun; 30(6):2135-50. PubMed ID: 26884454
[TBL] [Abstract][Full Text] [Related]
10. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue.
Kim YJ; Hwang SJ; Bae YC; Jung JS
Stem Cells; 2009 Dec; 27(12):3093-102. PubMed ID: 19816956
[TBL] [Abstract][Full Text] [Related]
11. miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2.
Fierro-Fernández M; Busnadiego Ó; Sandoval P; Espinosa-Díez C; Blanco-Ruiz E; Rodríguez M; Pian H; Ramos R; López-Cabrera M; García-Bermejo ML; Lamas S
EMBO Rep; 2015 Oct; 16(10):1358-77. PubMed ID: 26315535
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis.
Das S; Kumar M; Negi V; Pattnaik B; Prakash YS; Agrawal A; Ghosh B
Am J Respir Cell Mol Biol; 2014 May; 50(5):882-92. PubMed ID: 24279830
[TBL] [Abstract][Full Text] [Related]
13. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
14. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis.
Liu G; Wang Y; Yang L; Zou B; Gao S; Song Z; Lin Z
J Cell Mol Med; 2019 May; 23(5):3583-3596. PubMed ID: 30869194
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis.
Wei Y; Kim TJ; Peng DH; Duan D; Gibbons DL; Yamauchi M; Jackson JR; Le Saux CJ; Calhoun C; Peters J; Derynck R; Backes BJ; Chapman HA
J Clin Invest; 2017 Oct; 127(10):3675-3688. PubMed ID: 28872461
[TBL] [Abstract][Full Text] [Related]
16. Identification of TGF-β receptor-1 as a key regulator of carbon nanotube-induced fibrogenesis.
Mishra A; Stueckle TA; Mercer RR; Derk R; Rojanasakul Y; Castranova V; Wang L
Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L821-33. PubMed ID: 26472812
[TBL] [Abstract][Full Text] [Related]
17. Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.
Zou M; Wang F; Gao R; Wu J; Ou Y; Chen X; Wang T; Zhou X; Zhu W; Li P; Qi LW; Jiang T; Wang W; Li C; Chen J; He Q; Chen Y
Sci Rep; 2016 Apr; 6():24747. PubMed ID: 27098600
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation.
Huang C; Xiao X; Yang Y; Mishra A; Liang Y; Zeng X; Yang X; Xu D; Blackburn MR; Henke CA; Liu L
J Biol Chem; 2017 Oct; 292(40):16420-16439. PubMed ID: 28726637
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-328, a Potential Anti-Fibrotic Target in Cardiac Interstitial Fibrosis.
Du W; Liang H; Gao X; Li X; Zhang Y; Pan Z; Li C; Wang Y; Liu Y; Yuan W; Ma N; Chu W; Shan H; Lu Y
Cell Physiol Biochem; 2016; 39(3):827-36. PubMed ID: 27497782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
